PentaBind
EF 2022 · AI-designed aptamer therapeutics for biopharma.
Same space
| Company | Category | Status | Program |
|---|---|---|---|
 kyron.bioShared: pharmaceuticals, biotechnology, therapeuticNot statedOther | Other | Not stated | EF2022 |
 immunitoAIShared: pharmaceuticals, biotechnology, therapeuticNot statedAI | AI | Not stated | EF2021 |
 Sensible BiotechnologiesShared: biotechnology, therapeuticActiveOther | Other | Active | YCS21 |
 Uncommon TherapeuticsShared: biotechnology, therapeutic, designedActiveOther | Other | Active | YCW25 |
 Eugit TherapeuticsShared: biotechnology, therapeuticActiveOther | Other | Active | YCS22 |
Also from EF in AI
All of EF
Programs
| Program | Cohort | Source |
|---|---|---|
 Entrepreneur First | 2022 | EF Page |
About PentaBind
- Category
- AI
- Location
- London
- Checked
- 2h ago
Tags: Biotechnology, Pharmaceuticals
PentaBind: questions
Which accelerators did PentaBind go through?
PentaBind is listed by Entrepreneur First (2022).
Where is PentaBind based?
PentaBind lists London as its location on Entrepreneur First's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.